Avammune Therapeutics
PrivateLast Round
Series A
May 7, 2025
Total Funding Raised
$24M
Momentum Score
50 /100
Company Overview
Avammune Therapeutics is a biopharmaceutical company developing a pipeline of small-molecule drugs designed to modulate the innate immune system for treating cancer and autoimmune disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Avammune Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Avammune Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | May 7, 2025 | ||||
| Series A | May 7, 2024 | ||||
| Angel | Jul 15, 2022 | ||||
| Seed | Jul 9, 2019 |
Avammune Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| The Chennai Angels | Angel |
| Shastra VC | Series A |
| 1Crowd | Series A |
| Capital 2B | Series A |
| IvyCap Ventures | Series A |
| Kotak Alternate Asset Managers | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 13, 2026
Grew 21% QoQ, from 14 to 17 employees.
- Apr 26, 2026
Grew 45% QoQ from 11 to 16 employees.
Avammune Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Avammune Therapeutics's valuation, stock price, and market status.
